Current Choice for LDL-C Lowering in High-Risk CVD Patients Intolerant to Statins

Author(s): Zlatko Fras*

Journal Name: Current Vascular Pharmacology

Volume 19 , Issue 4 , 2021


Become EABM
Become Reviewer
Call for Editor

Keywords: Atherosclerosis, statin intolerance, ezetimibe, evolocumab, alirocumab, statins.

free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 4
Year: 2021
Published on: 24 March, 2021
Page: [398 - 402]
Pages: 5
DOI: 10.2174/157016111904210216104403

Article Metrics

PDF: 32